Methamphetamine dependence
Information
- Disease name
- Methamphetamine dependence
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04907357 | Active, not recruiting | N/A | rTMS for Stimulant Use Disorders | February 4, 2022 | July 2024 |
NCT00284206 | Completed | Phase 2 | A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence | January 2006 | August 2007 |
NCT00332605 | Completed | Phase 2 | N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence | June 2006 | January 2010 |
NCT00469508 | Completed | Phase 2 | Modafinil vs Placebo for the Treatment of Methamphetamine Dependence | April 2007 | January 2009 |
NCT01860807 | Completed | Phase 2 | Trial of Ibudilast for Methamphetamine Dependence | July 2013 | December 31, 2017 |
NCT01354470 | Completed | Phase 2 | A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence | October 2011 | |
NCT01359930 | Completed | Phase 1 | Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study | August 2011 | June 2012 |
NCT01365819 | Completed | Phase 2 | Varenicline for Methamphetamine Dependence | February 2012 | August 2014 |
NCT01377662 | Completed | Phase 2 | PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND) | August 2011 | May 2013 |
NCT01557569 | Completed | Phase 1/Phase 2 | Clinical Efficacy of Atomoxetine for Methamphetamine Dependence | April 2012 | July 2015 |
NCT01571167 | Completed | Phase 1 | Varenicline as a Treatment for Methamphetamine Dependence | January 2011 | February 2012 |
NCT01577797 | Completed | Phase 1 | A Cognitive Behavioral Therapy-Based Text Messaging Intervention for Methamphetamine Dependence | April 2012 | July 2013 |
NCT01685463 | Completed | N/A | Transcranial Magnetic Stimulation Used to Both Measure Cortical Excitability and Explore Methamphetamine Cue Craving | September 2008 | September 2014 |
NCT01822730 | Completed | Phase 4 | A Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated Psychosis | February 2013 | May 2014 |
NCT01825928 | Completed | N/A | An Study of Paliperidone Extended-Release Tablets in the Treatment of Methamphetamine Dependence | February 2013 | July 2014 |
NCT01843205 | Completed | Phase 1 | Buspirone as a Candidate Medication for Methamphetamine Abuse | April 2013 | March 2017 |
NCT00227123 | Completed | N/A | A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence | October 2002 | November 2006 |
NCT01967381 | Completed | Early Phase 1 | Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse | October 2013 | September 2018 |
NCT02034201 | Completed | Phase 1 | Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence | February 2014 | May 19, 2016 |
NCT02058966 | Completed | Early Phase 1 | Pilot Study of Entacapone for Methamphetamine Abuse | June 2014 | June 2016 |
NCT00520286 | Completed | Phase 2 | Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence | December 2007 | March 2010 |
NCT00569374 | Completed | Phase 2 | Safety and Tolerability of Modafinil for Methamphetamine Dependence | September 2007 | |
NCT00603434 | Completed | Phase 1 | Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH) | January 2008 | March 2009 |
NCT00653263 | Completed | Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study | August 2006 | August 2008 | |
NCT00687713 | Completed | Phase 2 | Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence | May 2008 | May 2011 |
NCT00731133 | Completed | Phase 1/Phase 2 | Open-Label Disulfiram for Methamphetamine Dependence | August 2008 | September 2010 |
NCT00751023 | Completed | Phase 4 | Effects of Modafinil in Methamphetamine Dependence | February 2009 | July 2010 |
NCT00833443 | Completed | Phase 2 | Study of Medical Treatment for Methamphetamine Addiction | January 2009 | July 2013 |
NCT00882037 | Completed | Risk and Protective Factors for Rural Methamphetamine Dependence | December 12, 2008 | December 15, 2010 | |
NCT00950352 | Completed | Phase 3 | Citicoline Treatment of Methamphetamine Dependence | January 2010 | December 2012 |
NCT00984360 | Completed | Phase 2 | Study of Naltrexone for Methamphetamine Addiction | September 2009 | September 2012 |
NCT01007539 | Completed | Phase 3 | Efficacy and Safety of CDP-choline in Patients With Methamphetamine Dependence | November 2009 | January 2012 |
NCT01011829 | Completed | Phase 2 | Varenicline vs Placebo for the Treatment of Methamphetamine Dependence | November 2009 | May 2010 |
NCT01062451 | Completed | Phase 1 | An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence | May 2009 | November 20, 2013 |
NCT01063205 | Completed | Phase 1 | NAC as a Potential Treatment for Methamphetamine Dependence | March 2010 | July 2011 |
NCT01071356 | Completed | Phase 2 | Intensive Motivational Interviewing for Methamphetamine Dependence | February 2009 | October 2012 |
NCT01073319 | Completed | Phase 1 | Rivastigmine as a Treatment for Methamphetamine Dependence | July 2009 | July 2010 |
NCT01077024 | Completed | Phase 3 | Smoking-Cessation and Stimulant Treatment (S-CAST) | February 2010 | August 2012 |
NCT01215929 | Completed | Phase 2 | Studying Amphetamine Withdrawal in Humans | October 2009 | May 2014 |
NCT02568878 | Recruiting | Phase 3 | Creatine for Depressed Male and Female Methamphetamine Users | November 2015 | May 2017 |
NCT00730522 | Terminated | Phase 2 | Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence | July 2008 | November 2009 |
NCT00567866 | Terminated | Early Phase 1 | Methamphetamine-Quetiapine Interactions in Humans | January 2008 | September 2009 |
NCT00859573 | Terminated | Phase 2 | Modafinil for Methamphetamine Dependence | April 2009 | January 2010 |
NCT01813643 | Terminated | Phase 4 | A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated Psychosis | July 2012 | August 2014 |
NCT01019707 | Terminated | Phase 1 | Safety Assessment of Atomoxetine With MA IV Administration | October 2009 | December 2010 |
NCT01813656 | Terminated | Phase 4 | An Study of Aripiprazole in the Treatment of Methamphetamine Dependence | September 2012 | February 2014 |
NCT00519259 | Unknown status | Phase 1 | Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1 | February 2006 | |
NCT01273701 | Unknown status | N/A | Combination of Psychosocial Intervention and Slow Prosecutions for the Treatment of Methamphetamine Abuse/Dependence | January 2011 | December 2012 |
NCT01044238 | Unknown status | Phase 2 | Methylphenidate to Treat Methamphetamine Dependence | October 2010 | July 2014 |
NCT01919437 | Unknown status | N/A | Comparison of Methamphetamine-Dependent and Healthy Volunteers Using a Web-Enabled Cognitive Neuropsychological Evaluation System | April 2012 | October 2013 |
NCT00439504 | Unknown status | Phase 1 | Ph1 Lobeline Interaction Study - 1 | ||
NCT01601717 | Withdrawn | Phase 1 | RTI-336 as a Treatment for Methamphetamine Dependence | January 2010 | January 2012 |
NCT00733967 | Withdrawn | Phase 1 | Varenicline-Methamphetamine Interaction Study (2008) | January 2008 | August 2008 |
NCT00728312 | Withdrawn | Phase 4 | Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial | August 2009 | April 2010 |